Upcoming Webinars for Dementia and Alzheimer’s Researchers

Neuroimaging PIA: Structural and Vascular Imaging

Oct. 6, 2021
9 a.m. CT

The latest advances in structural and vascular imaging will be discussed in the context of neurodegenerative diseases. The application of these imaging measures will be covered both in clinical practice and in research.

Speakers:
Joana Pereira and Prashanthi Vemuri

Biofluid Based Biomarkers in Neuropsychiatric Syndromes — The First Webinar

Oct. 6, 2021
11:30 a.m. CT

Biofluid biomarkers have established value predicting cognitive and functional decline. However, their associations with neuropsychiatric symptoms are widely unknown. Furthermore, neuropsychiatric syndromes may serve as proxy markers for neuropathological change. In this first webinar, we will discuss the current knowledge on biological predictors of neuropsychiatric syndromes and the role of biofluid biomarkers as outcome measures in longitudinal studies.

Speakers:
Corinne Fischer and Rawan Tarawneh

Clinical Implementation of Blood-Based Biomarkers: Global Perspectives, Science and Health Economics

Oct. 12, 2021
10 a.m. CT

This collaborative webinar between the Biofluid Biomarkers PIA and Health Policy PIA will discuss factors remaining to be addressed from the scientific standpoint on the road to implementation. We will consider implications for patient-informed consent, interpretation of results and ways to study the potential health economics impact, which might vary according to geography/setting.

Panelists:
Ashvini Keshavan, Jalayne Arias and Soeren Mattke

Neuroimaging PIA: AIC Spotlight

Oct. 14, 2021
9 a.m. CT

This webinar spotlights new research selected from to AIC 2021 submissions. These talks cover the latest technical advances in ADADR neuroimaging research.

Speakers:
Kaitlin Stouffer, Tavia Evans, Leonardo Rivera-Rivera, Mario Torso, Jay Shah and Thomas Vaele

ISTAART Journal Club: Meet the Author

Oct. 14, 2021
11 a.m. CT

Hosted by the Cognition PIA.

Kaitlin Casaletto will lead a conversation with Jacob W. Vogel about the paper, Four Distinct Trajectories of Tau Deposition Identified in Alzheimer’s Disease, published in Nature Medicine.

Mark Liberman will lead a conversation with Elif Eyigoz, Guillermo Cecchi and Melissa Naylor about the paper, Linguistic Markers Predict Onset of Alzheimer's Disease, published in EClinicalMedicine.

ISTAART Methods Club: Qualitative Research Edition, in Collaboration with the Diversity and Disparities PIA

Oct. 26, 2021
3:30 p.m. CT

Have you ever wondered how you can understand a research participant’s story in rich detail from their own perspective? Perhaps you want to combine this type of data with quantitative data. Come learn from early career researchers who carry out qualitative and mixed methods research. We are delighted to be joined by two experts in qualitative research methods for the question-and-answer section at the end of the webinar.

Presenters:
Andrea Gilmore-Bykovskyi, Jean-François Trani, Robert W. Turner and Paris "AJ" Adkins-Jackson

EEG Biomarkers of Brain Health and Dementia: Advances from the Latin American Research Network and ISTAART Electrophysiology PIA

Oct. 29-30, 2021
10 a.m. CT

Hosted by the Latin American Brain Health Institute (Brain Lat), Latin-American and Caribbean Consortium on Dementia (LAC-CD), Alzheimer's Association and the ISTAART Electrophysiology PIA.

Join this two-day webinar meeting, which will cover EEG biomarkers of brain health and dementia, promising methodological developments, global initiatives, scalability of EEG technologies and more.

Immunity PIA and PEERs PIA: Methods Club – Models of Immunity and Neurodegeneration – From Cells and Mice to Humans

Nov. 2, 2021
8:30 a.m. CT

Have you ever wondered how we study immunity and neurodegeneration in the lab? Come learn from 3 early career researchers who investigate immunity and neurodegeneration in cell lines, mice, marmosets, and humans. We are delighted to be joined by two experts from the immunity and neurodegeneration field for the question-and-answer section at the end of the webinar.

Presenters:
Britanni Price, Mike Daniels, Kristen Onos, Sarah Hopp and Oliver Bracko

Neuroimaging PIA: fMRI and FDG PET

Nov. 3, 2021
9 a.m. CT

The latest advances in functional MRI and FDG PET will be discussed in the context of neurodegenerative diseases. The application of these imaging measures will be covered both in clinical practice and in research.

Speakers:
Anne Maass and Leonardo Iaccaroni

Neuroimaging PIA: Translational Neuroscience: What We Can Learn from Animal Models

Nov. 18, 2021
9 a.m. CT

In this webinar, Scott Small and Amy Arnsten will give an update on neuroimaging in animal models and will discuss how this type of research is important for translation of basic research to human patients.

Speakers:
Scott Small and Amy Arnsten

Immunity PIA: Reactive Astrocytes as Diagnostic and Therapeutic Targets in Alzheimer’s Disease and Related Disorders

Nov. 19, 2021
10 a.m. CT

Most research in the Alzheimer’s disease (AD) field has focused on neurons or microglia as the primary cellular drivers of pathophysiology. This webinar will present evolving evidence — based on advances in molecular, imaging and cell specific-targeting strategies — that highlights the diagnostic and therapeutic potential of reactive astrocytes in AD and related disorders.

Presenters:
Agneta Nordberg, Elena Galea and Chris Norris

Neuroimaging PIA: Amyloid and Tau PET

Dec. 1, 2021
9 a.m. CT

The latest advances in amyloid and tau PET will be discussed in the context of neurodegenerative diseases. The application of these imaging measures will be covered both in clinical practice and in research.

Speakers:
Gil Rabinovici and Michael Scholl

Neuroimaging PIA: Big Data Analyses in Neuroimaging

Dec. 16, 2021
9 a.m. CT

With the advent of megadata in neuroimaging research, novel statistical techniques for analyses and discovery become available. This webinar will give an update of the latests developments in the field.

Presenter:
Neda Jahansad

Neuroimaging PIA: In Vivo Imaging Versus Neuropathology

Jan. 12, 2022
9 a.m. CT

An introduction will be given to the basics and neuropathologic diagnostics of both beta-amyloid and tau. Additionally, it will be discussed how PET imaging measures of beta-amyloid and tau relate to the post-mortem measures of these pathologies.

Speakers:
Melissa Murray and Dietmar Thal